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Abstract
This paper derives a new family of estimators, namely the minimum density power divergence
estimators, as a robust generalization of the maximum likelihood estimator for the polytomous
logistic regression model. Based on these estimators, a family of Wald-type test statistics for linear
hypotheses is introduced. Robustness properties of both the proposed estimators and the test
statistics are theoretically studied through the classical influence function analysis. Appropriate
real life examples are presented to justify the requirement of suitable robust statistical procedures in
place of the likelihood based inference for the polytomous logistic regression model. The validity of
the theoretical results established in the paper are further confirmed empirically through suitable
simulation studies. Finally, an approach for the data-driven selection of the robustness tuning
parameter is proposed with empirical justifications.
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1 Introduction
The polytomous logistic regression model (PLRM) is widely used in health and life sciences for ana-
lyzing nominal qualitative response variables (e.g., Daniels and Gatsonis, 1997; Blizzard and Hosmer,
2007; Bull, Lewinger and Lee, 2007; Dreassi, 2007; Biesheuvel et al., 2008; Bertens et al., 2015; Dey,
Raheem and Lu, 2016; Ke, Fu and Zhang, 2016, and the references therein). Such examples occur
frequently in medical studies where disease symptoms may be classified as absent, mild or severe, the
invasiveness of a tumor may be classified as in situ, locally invasive, or metastatic, etc. The qualita-
tive response models specify the multinomial distribution for such a response variable with individual
category probabilities being modeled as a function of suitable explanatory variables. One such pop-
ular model is the PLRM, where the logit function is used to link the category probabilities with the
explanatory variables.
Mathematically, let us assume that the nominal outcome variable Y˜ has d+1 categories C1, ..., Cd+1
and we observe Y˜ together with k explanatory variables with given values xh, h = 1, ..., k. In addition,
assume that βTj = (β0j , β1j , ..., βkj) , j = 1, ..., d, is a vector of unknown parameters and βd+1 is a
(k + 1)-dimensional vector of zeros; i.e., the last category Cd+1 has been chosen as the baseline
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category. Since the full parameter vector βT = (βT1 , ...,β
T
d ) is ν-dimensional with ν = d(k + 1), the
parameter space is Θ = Rd(k+1). Let πj (x,β) = P (Y˜ ∈ Cj | x,β) denote the probability that Y˜
belongs to the category Cj for j = 1, ..., d+1, when the vector of explanatory variable takes the value
xT = (x0, x1, . . . , xk), with x0 = 1 being associated with the intercept β0j . Then, the PLRM is given
by
πj (x,β) = exp(x
Tβj)
/{
1 +
d∑
h=1
exp(xTβh)
}
, j = 1, ..., d + 1. (1)
Now assume that we have observed the data on N individuals having responses y˜i with associated
covariate values (including intercept) xi ∈ Rk+1, i = 1, ..., N , respectively. For each individual, let
us introduce the corresponding tabulated response yi = (yi1, ..., yi,d+1)
T with yir = 1 and yis = 0
for s ∈ {1, ..., d + 1} − {r} if y˜i ∈ Cr. The most common estimator of β under the PLRM is the
maximum likelihood estimator (MLE), which is obtained by maximizing the loglikelihood function,
logL (β) ≡∑Ni=1∑d+1j=1 yij log πj (xi,β). One can then develop all the subsequent inference procedures
based on the MLE β̂ of β. Although the MLE has optimal asymptotic properties in relation to the
efficiency for most cases, its serious lack of robustness against the outlying observations is also a well-
known problem. However, in any practical dataset it is quite natural to have outlying observations
which can lead to incorrect inference for the likelihood based approach and can be very dangerous
specially in applications like medical sciences. The above formulation of the PLRM is not exclusive
only for distinct covariate values; it can also be applied, with the same notation, if multiple responses
are observed for the same covariate values. Let us begin with the following motivating example.
Example 1 (Mammography experience data) The mammography experience data, which assess
factors associated with women’s knowledge, attitude and behavior towards mammography, was intro-
duced in Hosmer and Lemeshow (2000); it is a subset of the original study by the University of
Massachusetts Medical School and recently studied by Mart´ın (2015). It involves N = 412 individuals,
k = 8 explanatory variables and a nominal response with d+1 = 3 categories (studied in detail in Sec-
tion 5). Here, all individuals do not have distinct covariate values so that their plots (e.g., Figure 1)
only distinguish 125 indices in its x-axis, which corresponds to the grouped observations for 125 distinct
covariates values available in the data. Following Mart´ın (2015), the grouped observations associated
with seven such distinct indices can be considered as outliers. A “good” robust statistical inference
procedure should not get highly affected by the presence of the outliers. So, we compute the MLE of β
under the PLRM for the full dataset and also for the outliers deleted dataset and plot the corresponding
(estimated) category probabilities for each available distinct covariate values. The left panel of Figure
1 presents these category probabilities for the second category, which clearly indicates the significant
variation of the MLE in the presence or absence of the outliers. In addition, the mean deviations
of the estimated probabilities with respect to the relative frequencies, shown in Figure 1 (right), are
always seen to be lower for the outlier deleted estimators. This introductory example clearly illustrates
the non-robust nature of the MLE and motivates us to look for a robust inference procedure that will
generate correct results with high efficiency even without removing the outlying observations. 
The term “outlier”needs a clarification when referring Mart´ın (2015). In logistic regression diag-
nostics, the Cook’s distance is a tool for identifying influential observations associated with specific
explanatory variables. In the current paper, the term “outlier”matches this notion of “influency ”but
not directly the term “outlying for having a large value of the residual”, as in Mart´ın (2015).
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Figure 1: MLE based estimates of (a) the response probabilities in category j = 2 (left) and (b) the
expected mean deviations of the estimated probabilities with respect to the corresponding relative
frequencies for each category j = 1, 2, 3 (right) in the Mammography experience data
There exist some alternative estimation procedures for the PLRM other than the MLE, although
they are used less often in practice; these include the estimators proposed by Begg and Gray (1984) and
its modification by Rom and Cohen (1995). The generalized method of moments (GMM) has also been
considered (Hayashi, 2000) which has been shown to be consistent and fully efficient under suitable
conditions. Gupta et al. (2006) considered the PLRM with only categorical covariates and discussed
the family of the minimum phi-divergence estimators (MφEs) that contains the MLE as a particular
case. The MφEs are BAN estimators and have high efficiency for moderate and small sample sizes.
However, the important issue of robustness against outliers was ignored in all these cited references.
Ronchetti and Trojani (2001) pointed out the non-robustness of the GMM estimators. Recently, Wang
(2014) gave a robust modification of the GMM estimator, whereas earlier Victoria-Feser and Ronchetti
(1997) had presented a robust estimator for grouped data with categorical covariates only.
In this paper, we present an alternative simple robust generalization of the MLE for the general
PLRM (1) by using the density power divergence (DPD) measure of Basu et al. (1998). The DPD
based inference has become very popular in recent time specially because of its strong robustness
properties against outliers; see, e.g., Basu et al. (2016, 2017a,b), Ghosh et al. (2016), among others.
In this paper, we first develop the estimator of β in the PLRM by minimizing a suitably defined
DPD measure and derive its asymptotic distribution in Section 2. In Section 3 the problem of testing
linear hypotheses in the PLRM is considered using the newly proposed estimators. The robustness of
both the proposed estimator and the test of hypothesis are studied theoretically through the influence
function analysis in Section 4. Section 5 presents some real data examples and Section 6 is devoted
to a simulation study. A method for the data-driven selection of the robustness tuning parameter is
described in Section 7. The paper ends with brief concluding remarks in Section 8. Proofs of the
results and further technical details are given in the online supplementary material.
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2 Minimum density power divergence estimator for the PLRM
The MLE β̂ of the parameter β under the PLRM in (1) can be equivalently defined as the minimizer
of the Kullback-Leibler divergence (KLD) between the probability vectors p̂ = 1N (y11, ..., y1,d+1, y21, ...,
y2,d+1, ..., yN1, ..., yN,d+1)
T and p(β) = 1N (pi1(β)
T , ...,piN (β)
T )T , where pii (β)
T = (πi1(β), . . . , πi,d+1(β)),
with πij(β) = πj (xi,β). This follows from the expression of the KLD between p̂ and p (β) given by
DKL (p̂,p (β)) =
N∑
i=1
d+1∑
j=1
yij
N
log
yij
πij (β)
= c− 1
N
N∑
i=1
d+1∑
j=1
yij log πij (β) , (2)
where c does not depend on β and hence β̂ = argminβ∈ΘDKL (p̂,p (β)).
The KLD is a particular case of the general DPD measure Dλ(·, ·) between p̂ and p (β)
Dλ (p̂,p (β)) =
1
Nλ+1
N∑
i=1

d+1∑
j=1
πλ+1ij (β)−
λ+ 1
λ
d+1∑
j=1
yilπ
λ
ij (β) +
1
λ
 .
Since the term 1λ does not have any role in the minimization of Dλ (p̂,p (β)) with respect to β, it is
sufficient to consider dλ (yi,pii(β)) =
∑d+1
j=1
{
πij (β)− λ+1λ yij
}
πij (β)
λ, and minimize
dλ (p̂,p (β)) =
1
Nλ+1
N∑
i=1
dλ (yi,pii(β)) . (3)
Definition 2 The minimum DPD estimator (MDPDE) of β with tuning parameter λ in the PLRM
(1) is given by β̂λ = arg min
β∈Θ
dλ (p̂,p (β)), where dλ (p̂,p (β)) is given in (3).
The DPD at λ = 0 is defined by the limit of the expression in (3) as λ→ 0, which coincides with
the KLD (2) up to an additive constant. Therefore, the MDPDE at λ = 0 is nothing but the MLE.
See Appendix for the detailed procedure to obtain the MDPDE.
Note that the random variables Y i associated with the tabulated response yi, given the covariate
value xi under the PLRM, are independent but non-homogeneous. So, we can apply the general
theory from Ghosh and Basu (2013) to study the properties of the MDPDE under the PLRM. In
fact, the minimization of the intuitive objective function (3) here is equivalent to the minimization
of the average DPD measure between the observed data and the model probability mass functions
over each distributions (indexed by i), which is proposed in Ghosh and Basu (2013) for the general
non-homogeneous set-up. Hence, based on their general theory, we obtain the asymptotic properties
of our MDPDE under the PLRM which is presented in the following theorem.
Theorem 3 Consider the PLRM (1) with the true parameter value being β0. Under Assumptions
(A1)–(A7) of Ghosh and Basu (2013), there exists a consistent MDPDE β̂λ of β and
√
N(β̂λ −
β0)
L→
N→∞
N (0d(k+1),J−1λ (β0)V λ (β0)J−1λ (β0)), where Jλ (β) = limN→∞ΨN,λ (β) and V λ (β) =
lim
N→∞
ΩN,λ (β) with
ΨN,λ (β) =
1
N
N∑
i=1
∆(pi∗i (β))diag
λ−1{pi∗i (β)}∆(pi∗i (β))⊗ xixTi , (4)
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ΩN,λ (β) =
1
N
N∑
i=1
∆(pi∗i (β))diag
λ−1{pi∗i (β)}∆(pi∗i (β))diagλ−1{pi∗i (β)}∆(pi∗i (β))⊗ xixTi . (5)
Here, ∆(p) = diag(p)− ppT , the vector with superscript ∗ denotes its subvector with the last element
removed and the vector with any other superscript takes the corresponding power for all its components.
3 Wald-type test statistics for testing linear hypotheses
Most testing problems for β in the PLRM belong to the class of linear hypotheses given by
H0 : L
Tβ = h against H1 : L
Tβ 6= h, (6)
where L is d(k + 1) × r full rank matrix with r ≤ d(k + 1) and h an r-vector. Two important
particular cases are the testing problems for H0 : β = β0 or H0 : β(s) = 0 against their respective
omnibus alternatives, where β(s) is a subvector of β.
Definition 4 Let β̂λ be the MDPDE of β in the PLRM (1) and denoteMN,λ(β̂λ) =Ψ
−1
N,λ(β̂λ)ΩN,λ(β̂λ)
Ψ−1N,λ(β̂λ). Then, the family of Wald-type test statistics for testing the null hypothesis given in (6) is
defined as
WN (β̂λ) = N(L
T β̂λ − h)T
{
LTMN,λ(β̂λ)L
}−1
(LT β̂λ − h). (7)
In particular, since β̂λ=0 = β̂, the MLE of β, and MN,λ=0(β̂) = Ψ
−1
N,λ=0(β̂) with
ΨN,λ=0 (β) = ΩN,λ=0 (β) =
1
N
N∑
i=1
∆(pi∗i (β))⊗ xixTi ,
being the Fisher information matrix, WN (β̂λ=0) becomes the classical Wald test statistic.
Theorem 5 The asymptotic distribution of the Wald-type test statistics, WN (β̂λ), under the null
hypothesis in (6), is a chi-square distribution (χ2r) with r degrees of freedom.
Based on Theorem 5, the null hypothesis in (6) will be rejected if WN (β̂λ) > χ
2
r,α, the upper α-th
quantile of χ2r. See Appendix for some results about its power function.
4 Robustness Properties
We first study the robustness of the proposed MDPDE of β under the PLRM (1) through the influence
function analysis. For any estimator defined in terms of a statistical functional U(G) in the set-up of
independent and identically distributed (IID) data from the true distribution function G, its influence
function is defined as IF (t,U , G) = lim
ǫ↓0
U(Gǫ)−U(G)
ǫ =
∂U(Gǫ)
∂ǫ
∣∣∣
ǫ=0
, where Gǫ = (1 − ǫ)G + ǫ∧t with
ǫ being the contamination proportion and ∧t being the degenerate distribution at the contamination
point t. Thus, the (first order) influence function (IF), as a function of t, measures the standardized
asymptotic bias (in its first order approximation) caused by the infinitesimal contamination at the
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point t. The maximum of this IF over t indicates the extent of bias due to contamination and hence
lower its value, the more robust the estimator is.
For the present case of PLRM, given the value of xi, yis are independent but not-identically
distributed. The extended definition of IF for such non-homogeneous cases has been proposed in Huber
(1983) and Ghosh and Basu (2013, 2016). Following the approach of the later, let Gi denote the true
distribution function of yi having joint mass function gi and Fi (β) denote the distribution function
under the assumption of PLRM having joint mass function fi(yi,β) = y
T
i pii (β) =
∑d+1
j=1 yijπij(β).
Denote G = (G1, · · · , GN )T , F (β) = (F1(β), · · · , FN (β))T and Y = {ej,d+1}d+1j=1 , where ej,d+1 is the
j-th column of the identity matrix of order d + 1. Note that, Y is the sample space of the response
variable Y i. Then, the statistical functional Uλ(G) corresponding to the proposed MDPDE, β̂λ, of
β is defined as the minimizer of
H(β) =
N∑
i=1
∑
yi∈Y
fλ+1i (yi,β)−
λ+ 1
λ
∑
yi∈Y
fλi (yi,β)gi(yi)
 ,
whenever it exists. When the assumption of PLRM holds with true parameter β0, we have gi(yi) =
fi(yi,β0), and thus H(β) = N
λ+1dλ (p (β0) ,p (β)); this is minimized at β = β0 implying the Fisher
consistency of the MDPDE functional Uλ(G) at the PLRM. Note that, in such non-homogeneous
settings, outliers can be either in any one or more index i ∈ {1, ..., N} for gi. Following the general
results from Ghosh and Basu (2013), one can derive the IF of the MDPDE at F (β0) as given by
IF i0(ti0 ;Uλ,F β0) = Ψ−1N,λ(β0)
1
N
(Id,0d)∆(pii0 (β) diag
λ−1{pi∗i0 (β0)}
{
t∗i0 − pi∗ (β0)
}⊗ xi0 ,
when there is contamination in only one specific index i0 at the point ti0 ∈ Y and
IF(t;Uλ,F (β0)) = Ψ−1N,τ (β0)
1
N
N∑
i=1
(Id,0d)∆(pii (β) diag
λ−1{pi∗i (β0)} {t∗i − pi∗ (β0)} ⊗ xi,
when the contamination is in all N distributions Gi at the points ti ∈ Y, respectively, for i = 1, . . . , N .
Here t = (t1, . . . , tN ).
Note that, these IFs are bounded in large xis (leverage points) for all λ > 0, but unbounded at
λ = 0 (the MLE). This implies that the proposed MDPDEs with λ > 0 are robust against leverage
points, but the classical MLE is clearly non-robust. However, we cannot directly infer about the
robustness against outliers in the response variable which are, in fact, the misspecification errors.
This is because, in such cases, ti changes its indicative category only (does not go to infinity) and the
IFs are bounded in tis for all λ ≥ 0. But, it is well studied that the MLE at λ = 0 is highly non-robust
against these misspecification errors. In the next two sections, we will empirically illustrate the strong
robustness of our proposed MDPDEs with λ > 0 also against such misspecification errors.
Next, we study the robustness of the proposed Wald-type test statistics. The IF of a testing
procedure, as introduced by Rousseeuw and Ronchetti (1979) for IID data, is also defined as in the
case of estimation but with the statistical functional corresponding to the test statistics and it is studied
under the null hypothesis. This concept has been extended to the non-homogeneous data, which is
the case here, by Ghosh and Basu (2017), Aerts and Haesbroeck (2017) and Basu et al. (2017b); the
last one considered the general Wald-type test statistics. The associated statistical functional for our
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Wald-type test statistics (7) can be defined as (ignoring the multiplier N)
Tλ (G) =
{
LTUλ(G)− h
}T {
LTMN,λ(Uλ(G))L
}−1 {
LTUλ(G)− h
}
, (8)
where Uλ(G) is the MDPDE functional. Again we can have contamination in either one or all
distributions as before and the corresponding IFs can be obtained from the general theory of Basu et
al. (2017b). Letting β0 be the true null parameter value under (6), the (first order) IFs in either case
of contamination become identically zero at G = F (β0).
Thus the first order bias approximation is not much informative for the Wald-type test statistics
and we need to study their second order bias approximation, quantified through the second order IFs
which we denote by IF (2). It is defined as the second order derivative of the functional value at Gε
with respect to the contamination proportion ε → 0+. Following Basu et al. (2017b), we can show
that, at the null distribution G = F (β0),
IF (2)(ti0 ;Tλ,F (β0)) = 2IF(ti0 ;Uλ,F (β0))TLT
{
LMN,λ(β0)L
T
}−1
LIF(ti0 ;Uλ,F (β0)),
IF(2)(t;Tλ,F (β0)) = 2IF(t;Uλ,F (β0))TLT
{
LMN,λ(β0)L
T
}−1
LIF(t;Uλ,F (β0)),
for contamination only in i0-th distribution or in all distributions, respectively. Clearly, the bounded-
ness of these IFs directly depend on that of the MDPDE. Hence, the proposed Wald-type test statistics
with λ > 0 are expected to be robust, whereas the classical Wald test statistic at λ = 0 is non-robust
against infinitesimal contamination.
5 Numerical Examples
5.1 Mammography experience data (Hosmer and Lemeshow)
Let us reconsider our motivating example, the mammography experience data, to study the per-
formance of our proposed robust procedures. As noted in Section 1, this dataset involves k = 8
explanatory variables with all of them being dummy variables, except one. Among them, three
dummy variables are associated with four categories of the variable SYMPT (‘You do not need a
mammogram unless you develop symptoms’: 1, strongly agree; 2, agree; 3, disagree; 4, strongly
disagree), the fourth dummy variable represents two categories of variable HIST (‘Mother or sister
with a history of breast cancer’: 1, no; 2, yes), the fifth dummy variable corresponds to two cate-
gories of variable BSE (‘Has anyone taught you how to examine your own breasts?’: 1, no; 2, yes)
and other two dummy variables are associated with three categories of the variable DETC (‘How
likely is it that a mammogram could find a new case of breast cancer?’: 1, not likely; 2, somewhat
likely; 3, very likely). The final explanatory variable is a quantitative variable representing the PB
score (“Perceived benefit of mammography”: values between 5 and 20, with the lowest value rep-
resenting the highest benefit perception). The response variable ME (Mammography experience)
is a categorical factor with three levels: “Never”, “Within a Year” and “Over a Year” (d = 2).
Hence, β̂
T
λ = (β̂
T
1,λ, β̂
T
2,λ), with β̂
T
j,λ = (β̂0j,λ, β̂1j,λ, . . . , β̂8j,λ), j = 1, 2, and β̂1j,λ = β̂SYMPT1,j,λ,
β̂2j,λ = β̂SYMPT2,j,λ, β̂3j,λ = β̂SYMPT3,j,λ, β̂4j,λ = β̂HIST,j,λ, β̂5j,λ = β̂BSE,j,λ, β̂6j,λ = β̂DETC1,j,λ,
β̂7j,λ = β̂DETC2,j,λ, β̂8j,λ = β̂PB,j,λ.
As suggested by Mart´ın (2015), the groups of observations associated with covariate values xi for
i equal to 1, 3, 17, 35, 75, 81 and 102 can be treated as outliers; the MDPDEs of β obtained with
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and without these outliers are presented in Table 1–2 in Appendix A.4. One important difference is
observed in β̂52,λ = β̂BSE,2,λ; when outliers are deleted β̂BSE,2,λ > 0 whereas β̂BSE,2,λ < 0 for the full
data. Although it is observed for all values of λ, MDPDEs with moderate λ > 0 are quite near to zero
in both the cases, and hence they may not be significantly different. A deeper study of the MDPDEs
in this example is presented below.
Study of the Efficiency: For each category of the response variable, we have calculated the
estimated mean deviation (EMD) of the predicted probabilities with respect to the relative fre-
quencies of the response variable under presence or absence of the outliers. These are defined
as m̂dj(β̂
⋆
λ) =
1
N
∑N
i=1
∣∣∣πij(β̂⋆λ)− p̂ij∣∣∣, j = 1, 2, 3, with ⋆ ∈ {pres, abs} and are reported in Ta-
ble 3 in Appendix A.4. We can see that the MLE yields the minimum average EMD, defined as
m̂d(β̂
⋆
λ) =
1
d+1
∑d+1
j=1 m̂dj(β̂
⋆
λ), and hence leads to the highest efficiency in the absence of outliers.
This efficiency decreases as λ increases, but the loss is not very significant. The simulation study,
presented in the next section, indicates the same behavior for pure data.
Study of Robustness: From Table 3 in Appendix A.4, the average EMDs in the presence of
outliers decrease significantly as λ increases from 0. This illustrates the increasing robustness of
our proposed MDPDEs with increasing λ > 0. In order to further examine the robustness of the
MDPDEs, we compute the average mean deviations between the predicted probabilities obtained in
presence and absence of the outliers, as given by m̂d(β̂
pres
λ , β̂
abs
λ ) =
1
d+1
∑d+1
j=1 m̂dj(β̂
pres
λ , β̂
abs
λ ) with
m̂dj(β̂
pres
λ , β̂
abs
λ ) =
1
N
∑N
i=1
∣∣∣πij(β̂presλ )− πij(β̂absλ )∣∣∣, j = 1, 2, 3. Their values, as presented in Table 4
of Appendix A.4, clearly show that the MDPDE becomes more robust as λ increases. This behavior
is also illustrated in Figure 2, where predicted category probabilities at each observed covariate values
are shown for λ = 0 (MLE, left) and λ = 0.7 (right). The differences between blue and orange points,
corresponding to the outlier deleted data and the full data, respectively, are quite significant for the
classical MLE but much more stable for the MDPDE at λ = 0.7.
As an illustration of the proposed Wald-type test for this dataset, we consider the problem of
testing H0 : βSYMPT1,1 = 0. The p-values obtained based on the proposed test are plotted over
λ in Figure 3 (left) for both the full and the outlier deleted data. Clearly the test decision at the
significance level α = 0.05 changes completely in the presence of outliers for smaller λ including the
classical Wald test at λ = 0. But the inference becomes much stable for larger λ ≥ 0.3 implying strong
robustness of our proposal.
5.2 Liver enzyme data (Plomteux)
Plomteux (1980) showed that the four levels of hepatitis can be explained based on three liver function
tests: aspartate aminotransferase (AST), alanine aminotransferase (ALT) and glutamate dehygroge-
nase (GIDH). The associated dataset (Albert and Harris, 1987) consists of 218 patients with their
hepatitis level being categorized as 1 = acute viral hepatitis, 2 = persistent chronic hepatitis, 3 =
aggressive chronic hepatitis and 4 = post-necrotic cirrhosis (d = 3). Their respective category fre-
quencies are 57, 44, 40 and 77. This dataset has been studied in the literature by Mun˜oz-Pichardo et
al (2011) and Mart´ın (2015), among others.
Here, we model these data with a PLRM where explanatory variables are taken to be the logarithms
of the three liver function tests, namely x = (1, log AST, log ALT, log GLDH)T . As suggested
in Mart´ın (2015), the observations associated with indices 93, 101, 108, 116, 131 and 136 of the
8
explanatory variables can be considered as outliers. Table 5 in Appendix A.4 shows the MDPDEs of
the model parameters in presence or absence of the outliers, while Table 6 in Appendix A.4 shows
the EMDs of the predicted probabilities with respect to the relative frequencies. In this case, all
the MDPDEs present a more efficient behavior than MLE even after removing the aforementioned
outliers; this indicates that perhaps there are still some masked outliers left in the data which were
unidentified by the previous studies. The advantage of the proposed MDPDEs under such cases is
clearly evident from this analysis.
Table 7 in Appendix A.4 shows the EMDs between the predicted probabilities obtained from the
full data and the outlier deleted data. Again, moderate and large values of λ > 0 yield lesser deviation
than that for the MLE, indicating their strong robustness against outliers. For testing H0 : β02 = 0,
the p-values of the proposed Wald-type tests are plotted in Figure 3. Note that, for λ = 0.5 the
p-values coincide for both the cases with or without outliers.
6 Simulation Study
6.1 Performance of the MDPDE
We consider a nominal outcome variable Y with d+1 = 3 categories, depending on k = 2 explanatory
variables x1 and x2. The true value of the parameter β = (β01, β11, β21, β02, β12, β22)
T is taken as
β0 = (0,−0.9, 0.1, 0.6,−1.2, 0.8)T . We first simulate pure samples of size N based on covariates
xi1 ∼ N (0, 1), xi2 ∼ N (0, 1) and the multinomial responses
yi ∼M (1;πi1(β0), πi2(β0), 1− πi1(β0)− πi2(β0)) , i = 1, . . . , N.
Then, to study the robustness, we additionally change the last p% of responses according to
yi ∼ M (1; 1 − πi1(β0)− πi2(β0), πi1(β0), πi2(β0)) , i =
[ p
100
N
]
+ 1, . . . , N.
Note that, although we have simulated the contaminated observations with a model-misspecification
point-of-view, it indeed also covers the cases of category misspecification. This is because, the con-
taminated responses are generated with permuted class probabilities, so that categories 1, 2, 3 in the
original data are now classified as category 2, 3, 1.
The mean square error (MSE) of the MDPDEs are computed based on 1000 such simulated samples
which are plotted in Figure 4 for different N , λ and p = 5% contaminations. In pure data, the MLE (at
λ = 0) presents the most efficient behavior having the least MSE for each sample sizes, while MDPDEs
with larger λ have slightly larger MSEs. For contaminated data the behavior of the MDPDEs is almost
the opposite; the best behavior (least MSE) is obtained for moderate values of λ. This becomes more
clear with larger sample sizes.
6.2 Performance of the MDPDE based Wald-type tests
Let us now empirically study the robustness of the MDPDE based Wald-type tests for the PLRM.
The simulation is performed with the same model as in Section 6.1. We first study the observed level
(measured as the proportion of test statistics exceeding the corresponding chi-square critical value) of
the test under the true null hypothesis H0 : β02 = 0.6. The resulting p-values are plotted in Figure 4
for both the pure and the 5% contaminated samples. In contaminated data, the level of the classical
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Wald test (at λ = 0) as well as the proposed Wald-type tests with small λ break down, while the
MDPDE based Wald-type tests for moderate and large positive λ yield greater stability in their levels.
To investigate the power robustness of these tests, we change the true data generating parameter
value to be β02 = 1.35 and the resulting empirical powers are plotted in Figure 4. Again, the classical
Wald test (at λ = 0) presents the best behavior under pure data, while the Wald-type tests with larger
λ > 0 lead to better stability in the contaminated samples.
7 On the choice of tuning parameter λ
Throughout the previous sections, we have noted that the robustness of both the proposed MDPDE
and the associated Wald-type tests increase with increasing λ; but their pure data (asymptotic)
efficiency and power decrease slightly. From our empirical analyses, it seems that a moderately large
value of λ is expected to provide the best trade-off for possibly contaminated data. However, a
data-driven choice of λ would be more helpful in practice.
As noted in Section 4, the robustness of the Wald-type test directly depends on that of the MDPDE
used. A useful procedure of the data-based selection of λ for the MDPDE was proposed by Warwick
and Jones (2005) under IID data, which is recently extended for the non-homogeneous data by Ghosh
and Basu (2013, 2015, 2016) and Basu et al. (2017a). We can adopt a similar approach to obtain a
suitable data-driven λ in our PLRM. In this approach, we minimize an estimate of the asymptotic MSE
of the MDPDE β̂λ, given by MSE(λ) = (βλ − β∗)T (βλ − β∗)+ 1N trace
{
J−1λ (βλ)V λ (βλ)J
−1
λ (βλ)
}
,
over λ ∈ [0, 1], where βλ is the asymptotic mean of β̂λ and β∗ is the true target parameter value. As
pointed out by Basu et. al (2017a), the estimation of the variance component should not assume the
model to be true for a better robustness trade-off. So, following the general formulation of Ghosh and
Basu (2015), model robust estimates of V λ and Jλ can be obtained as V̂ N,λ = ΩN,λ(β̂λ) and
ĴN,λ = (λ+ 1)ΨN,λ(β̂λ) +
1
N
N∑
i=1
∆
(
pi∗i (β̂λ)
)
d+1∑
j=1
πij(β̂λ)
λ+1
⊗ xixTi
− 1
N
N∑
i=1
{
λui(y
∗
i , β̂λ)ui(y
∗
i , β̂λ)
T +∆
(
pi∗i (β̂λ)
)
⊗ xixTi
}
fi(y
∗
i , β̂λ)
λ,
where ui and fi are given in Appendix. Next, for the bias part, we can use the MDPDE β̂λ to estimate
βλ but there is no clear choice for estimation of β
∗; Warwick and Jones (2005) suggested to estimate
β∗ by some appropriate pilot estimator βP . Note that, the overall performance of this procedure of
selecting optimum λ depends on the choice of βP , which we will explore through an empirical study.
Consider the same simulation study as in Section 6.1. We now compute the optimal λ value in each
iteration following the proposed method with a given βP . As potential choices of βP , we consider the
MDPDEs with “pilot” parameters λp ∈ {0, 0.3, 0.5, 1}. For example, when λp = 0.5, we fix βP = β̂0.5
and minimize the estimated quantity M̂SE(λ) =
(
β̂λ − β̂0.5
)T (
β̂λ − β̂0.5
)
+ 1N trace
(
Ĵ
−1
N,λV̂ N,λĴ
−1
Nλ
)
,
through a grid search over λ ∈ [0, 1], to obtain the optimum λ value. Note that, the bias term is not
generally zero even though we are using MDPDEs as the pilot estimator. Figure 5 shows the empirical
MSEs for the final MDPDEs with the resulting optimum λ (in each iteration) for the pure and the
contaminated data. Clearly, the best trade-off between the efficiency in pure data and the robustness
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under contaminated data is provided by the pilot choice λp = 0.3 and the corresponding MSEs are
also satisfactorily small in both the cases. So, we suggest to use the pilot choice βP = β̂0.3 for the
PLRM and the steps for the final algorithm are clearly mentioned below.
Algorithm for the data-driven selection of optimum tuning parameter λ
• Aim: Optimal fitting of the PLRM given a dataset
• Fix: Pilot estimate βP = β̂0.3. (Empirical suggestion)
• For each λ in a grid of [0, 1], do the following. (E.g., λ in 0 : 0.01 : 1)
– Compute the total estimated squared bias B(λ) =
(
β̂λ − β̂0.3
)T (
β̂λ − β̂0.3
)
.
– Compute the total estimated variance V (λ) = 1N trace
(
Ĵ
−1
N,λV̂ N,λĴ
−1
Nλ
)
.
– Compute the total estimated MSE as M̂SE(λ) = B(λ) + V (λ).
• Find: Minimum of M̂SE(λ) and the corresponding λ. Let λopt = argmin M̂SE(λ).
• Return: λopt as the final optimum value of the tuning parameter.
• Compute β̂λopt as your final estimate with optimally chosen tuning parameter.
We now apply this proposed algorithm (with a grid of spacing 0.05) to our real datasets. The
optimum λ turns out to be 1 and 0.75, respectively, for the Mammography experience data and the
Liver enzyme data in presence of the outliers. After deleting the aforementioned outliers from the
data, these optimum λ values become 0.05 and 0.35, respectively. These optimum λ values generate
quite stable MDPDEs for both datasets, as we have seen in Section 5. They indeed yield the automatic
data-driven choices of λ which are also consistent with the fact that we should use larger λ > 0 for
contaminated data and smaller λ close to zero for clean data. Note that, as discussed in Section
5, the liver enzyme data might contain some masked outlying observations even after removing the
aforementioned outliers from previous studies which leads to the slightly larger optimum λ value of
0.35. These evidences clearly justify the appropriateness and usefulness of our proposed algorithm of
selecting optimum data-driven λ for the MDPDEs in case of the PLRM.
8 Concluding Remarks
The PLRM is an extensively applied statistical tool which is widely used in many different areas,
including health and life sciences. Although the classical inference procedures based on the MLE
have asymptotic optimal properties, they are highly non-robust against outliers in data. So, there
is a strong need for robust procedures in practical applications of the PLRM due to the presence of
potential outlying observations in many real datasets. Here we derive a new family of estimators,
MDPDEs, as a robust generalization of the MLE for the PLRM, exploring the “nice” robustness
properties of the DPD measure. A family of Wald-type test statistics based on the MDPDEs is also
introduced for testing linear hypotheses under the PLRM. The study of two real data examples from
medical sciences as well as the simulation results illustrate the advantages of our proposed inference
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procedures.
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A Supplementary Materials: Appendices and Tables referenced in
Sections 3, 5 6 and 7
A.1 How to obtain the MDPDEs?
Consider the set-up and notations of Section 2 of the main paper. The following theorem presents the
estimating equation for the MDPDEs in the PLRM, which can be solved numerically to obtain the
estimates.
Theorem 6 The MDPDE, β̂λ, of β can be obtained by solving the system of equations
uλ (β) = 0d(k+1),
where
uλ (β) =
N∑
i=1
[
(Id,0d)∆(pii (β))diag
λ−1{pii (β)}{yi − pii (β)}
]
⊗ xi
Proof. The MDPDE of β, is defined as
β̂λ = argmin
β∈Rd(k+1)
N∑
i=1
{
pii (β)− λ+ 1
λ
yi
}T
pi
(λ)
i (β)
= argmin
β∈Rd(k+1)
N∑
i=1
d+1∑
j=1
{
πλ+1ij (β)−
λ+ 1
λ
yijπ
λ
ij(β)
}
,
which can also be obtained by solving the system of equations uλ (β) = 0d(k+1) where
− 1
λ+ 1
∂
∂β
N∑
i=1
{
pii (β)− λ+ 1
λ
yi
}T
pi
(λ)
i (β) = 0d(k+1),
N∑
i=1
d+1∑
j=1
{yij − πij(β)}πλ+1ij (β)
∂
∂β
πij(β) = 0d(k+1),
N∑
i=1
∂
∂β
pii (β)
T diagλ−1{pii (β)}{yi − pii (β)} = 0d(k+1).
Now, taking into account that
∂πij(β)
∂βuv
= xiuπij(β) {δjv − πiv(β)} , u = 1, ..., k, v = 1, ..., d,
we get
∂pii(β)
T
∂β
= (Id,0d)∆(pii (β))⊗ xi, (9)
and hence the system of equations becomes
N∑
i=1
[
(Id,0d)∆(pii (β))diag
λ−1{pii (β)}{yi − pii (β)}
]
⊗ xi = 0d(k+1).
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Note that, under the PLRM, the tabulated response variables Y i, i = 1, ..., N , are independent but
not identically distributed since the covariates xi are generally assumed to be pre-fixed (and hence
different over i). In particular, for each i = 1, . . . , N , given xi, Y i has a multinomial distribution
having joint probability mass function
fi(yi,β) =
d+1∏
j=1
πij (β)
yij =
d+1∑
j=1
yijπij (β) , yij ∈ {0, 1} for j = 1, . . . , d+ 1, with
d+1∑
j=1
yij = 1. (10)
This distribution indeed belongs to the family of d-dimensional Generalized Linear Models (GLM),
where the distribution of Y ∗i = (Yi1, . . . , Yid)T can be written as
fi(y
∗
i ,β) = exp
{
ηTi y
∗
i − b(ηi)
}
,
ηi = (ηi1, ..., ηid)
T , ηij = x
T
i βj , j = 1, ..., d,
b(ηi) = log
1 +
d∑
j=1
exp(ηij)
 .
The general estimating equation of Ghosh and Basu (2013), based on these forms of the model densities,
can be seen to coincide with the one given in Theorem 1.
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A.2 Power function of the Wald-type tests
Consider the set-up and notations of Section 3 of the main paper. We consider β∗ ∈ Θ such that
LTβ∗ 6= h, i.e., β∗ does not satisfy the null hypothesis given in Equation (6) of the main paper. Let
us denote
qβ1(β2) =
(
LTβ1 − h
)T {
LTΣλ (β2)L
}−1 (
LTβ1 − h
)
(11)
and derive an approximation to the power function for the MDPDE based Wald-type test with the
rejection rule given by
WN (β̂λ) > χ
2
r,α. (12)
Theorem 7 Let β∗ ∈ Θ, with LTβ∗ 6= h, be the true value of the parameter such that β̂λ P−→
N→∞
β∗.
The power function of the Wald-type test given in (12), is given by
βN,λ (β∗) = 1−ΦN
(
1
σλ (β∗)
(
χ2s,α√
N
−
√
Nqβ
∗
(β∗)
))
(13)
where ΦN (x) uniformly tends to the standard normal distribution function Φ(x) as N →∞ and
σλ (β∗) = 2
√(
LTβ∗ − h
)T {
LTΣλ (β∗)L
}−1 (
LTβ∗ − h
)
.
Proof. We have
βN,λ (β∗) = Pr
(
WN (β̂λ) > χ
2
r,α
)
= Pr
(
N
(
q
β̂λ
(β̂λ)− qβ∗(β∗)
)
> χ2r,α −Nqβ∗(β∗)
)
= Pr
(√
N
(
q
β̂λ
(β̂λ)− qβ∗(β∗)
)
>
χ2r,α√
N
−
√
Nqβ
∗
(β∗)
)
.
Note that, since β̂λ
P−→
N→∞
β∗, qβ̂λ(β̂λ) and qβ̂λ(β∗) have the same asymptotic distribution. But, a
first Taylor expansion of qβ(β∗) around β
∗ at β̂λ gives
q
β̂λ
(β∗)− qβ∗(β∗) =
∂qβ(β∗)
∂βT
∣∣∣∣
β=β
∗
(β̂λ − β∗) + op
(∥∥∥β̂λ − β∗∥∥∥) .
Therefore, √
N(q
β̂λ
(β̂∗)− qβ∗(β∗))
L−→
N→∞
N
(
0, σλ (β∗)
2
)
where
σλ (β∗)
2 =
∂qβ(β∗)
∂βT
∣∣∣∣
β=β
∗
Σλ (β∗)
∂qβ(β∗)
∂β
∣∣∣∣
β=β
∗
.
But
∂qβ(β∗)
∂βT
∣∣∣∣T
β=β
∗
= 2
(
LTβ∗ − h
) {
LTΣλ (β∗)L
}−1
LT ,
and hence the result follows.
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Remark 8 Based on the previous theorem we can obtain the minimum sample size which is necessary
to achieve a fix power, say βN,λ (β∗) = β. Based in equation (13), we must solve the equation
1− β = Φ
(
1
σλ (β∗)
(
χ2r,α√
N
−
√
Nqβ
∗
(β∗))
)
and we get that N = [N∗] + 1 with
N∗ =
A+B +
√
A(A+ 2B)
2qβ
∗
(β∗)2
being A = σλ (β∗)
2 (Φ−1 (1− β))2 and B = 12χ2r,αqβ∗(β∗) and qβ∗(β∗) is given in (11).
Remark 9 It also follows from Theorem 7 that βN,λ(β
∗) → 1, as N → ∞, for all λ ≥ 0. Therefore
the proposed MDPDE based Wald-type tests are consistent at any fixed alternative.
We now derive the asymptotic power function for the Wald-type test with the rejection rule given in
(12) at an alternative hypothesis close to the null hypothesis. Consider the parameter value βN ∈ Θ
with LTβ N 6= h, and the alternative hypothesis given by β = βN . Suppose β0 be the closest
parameter value to βN in the Euclidean distance such that L
Tβ0 = h. A first possibility to introduce
such contiguous alternative hypotheses is to consider a fixed d ∈ Rkd and to permit βN moving
towards β0 as N increases in the following way
H1,N : β = βN = β0 +N
−1/2d. (14)
A second approach is to relax the existence of a closest element β0 in the null parameter space and
consider the sequence βN such that for δ ∈ Rkd, it satisfies
H∗1,N : L
TβN = h−N−1/2δ. (15)
Note that, whenever the closest null parameter β0 exists, we have
LTβN − h = LTβ0+LT N−1/2d− h = N−1/2LTd. (16)
Then the equivalence between the two hypotheses (14) and (15) is given by
LTd = δ. (17)
If we denote by χ2r(∆) the non central chi-square distribution with r degrees of freedom and
non-centrality parameter ∆, we can state the following theorem.
Theorem 10 We have
i) WN (β̂λ)
L−→
N→∞
χ2r (∆1) under H1,N given in (14), with ∆1 = d
TL
{
LTΣλ (β0)L
}−1
LTd.
ii) WN (β̂λ)
L−→
N→∞
χ2r (∆2) under H
∗
1,N given in (15), with ∆2 = δ
T
{
LTΣλ (β0)L
}−1
δ.
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Proof. We have
LT β̂λ − h = LTβN − h+ LT (β̂λ − βN )
= LTβ0 +L
TN−1/2d− h+ LT (β̂λ − βN )
= LTN−1/2d+ LT (β̂λ − βN ).
Therefore,
Lβ̂λ − h = LTN−1/2d+ LT (β̂λ − βN ).
We know, under H1,N , that
√
N(β̂λ − βN ) L−→
N→∞
N (0d(k+1),Σλ (βN ))
and βN −→
N→∞
β0. Therefore
√
N(β̂λ − βN ) L−→
N→∞
N (0d(k+1),Σλ(β0))
and √
N(LT β̂λ − h) L−→
N→∞
N (LTd,LTΣλ(β0)L) .
But we know: “If Z ∈ N (µ,Σ), Σ is a symmetric projection of rank k and Σµ = µ, then ZTZ is a
chi-square distribution with k degrees of freedom and non-centrality parameter µTµ”. The quadratic
form is
WN (β̂λ) = Z
TZ
with
Z =
√
N
{
LTMN,λ(β̂λ)L
}−1/2
(LT β̂λ − h)
and
Z
L−→
N→∞
N
((
LTΣλ(β0)L
)−1/2
LTd, Ir
)
.
Hence, the result of i) is immediately verified and the non-centrality parameter takes the form
dTL
{
LTΣλ(β0)L
}−1
LTd.
For ii), we can follow (17).
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A.3 Proofs of the Theorems in the main paper
Proof of Theorem 1 of the main paper:
Let y∗i = (yi1, . . . , yid)
T be the reduced version of yi and
Y∗ = 0d ∪ {ej,d}dj=1,
the sample space of the (reduced) response vector, where ej,d is the j-th column of the identity matrix
of order d. From Theorem 3.1 of Ghosh and Basu (2013), we get the first part on consistency as well
as
Ω
−1/2
N,λ (β0)ΨN,λ (β0)
√
N(β̂λ − β0) L−→
N→∞
N (0d(k+1), Id(k+1)) ,
where
ΨN,λ (β) =
1
N
N∑
i=1
∑
y∗i∈Y∗
ui(y
∗
i ,β)ui(y
∗
i ,β)
T fλ+1i (y
∗
i ,β),
ΩN,λ (β) =
1
N
N∑
i=1
 ∑
y∗i∈Y∗
ui(y
∗
i ,β)ui(y
∗
i ,β)
T fi(y
∗
i ,β)
1+2λ − ξi,λ (β0) ξi,λ (β0)T
 ,
and
ξi,λ (β) =
∑
y∗i∈Y∗
ui(y
∗
i ,β)fi(y
∗
i ,β)
λ+1,
with ui(y
∗
i ,β) =
∂
∂β ln fi(y
∗
i ,β) = (y
∗
i − pi∗i (β))⊗ xi. The calculations of the matrix ΨN,λ (β) are as
follows
ΨN,λ (β) =
1
N
N∑
i=1

d∑
j=1
ui(ej,d,β)ui(ej,d,β)
T fλ+1i (ej,d,β) + ui(0d,β)ui(0d,β)
T fλ+1i (0d,β)

=
1
N
N∑
i=1
 d∑
j=1
{(ej,d − pi∗i (β))⊗ xi} {(ej,d − pi∗i (β))⊗ xi}T πλ+1ij (β)
+ {pi∗i (β)⊗ xi} {pi∗i (β)⊗ xi}T πλ+1i,d+1 (β)
]
=
1
N
N∑
i=1
 d∑
j=1
{
πλ+1ij (β) (ej,d − pi∗i (β))(ej,d − pi∗i (β))T
}
⊗ xixTi
+
{
πλ+1i,d+1 (β)pi
∗
i (β)pi
∗
i (β)
T
}
⊗ xixTi
]
=
1
N
N∑
i=1
 d∑
j=1
[
πλ+1ij (β) {ej,d − pi∗i (β)} {ej,d − pi∗i (β)}T
]
+ πλ+1i,d+1 (β)pi
∗
i (β)pi
∗
i (β)
T
]
⊗ xixTi
=
1
N
N∑
i=1

d∑
j=1
πλ+1ij (β) ej,de
T
j,d −
 d∑
j=1
πλ+1ij (β)ej,d
pi∗i (β)T
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− pi∗i (β)
 d∑
j=1
πλ+1ij (β) ej,d
T +
 d∑
j=1
πλ+1ij (β)
pi∗i (β)pi∗i (β)T
+πλ+1i,d+1 (β)pi
∗
i (β)pi
∗
i (β)
T
}
⊗ xixTi
=
1
N
N∑
i=1
[
diagλ+1{pi∗i (β)} − pi∗(λ+1)i (β)pi∗i (β)T − pi∗i (β)pi∗(λ+1)i (β)T
+
d+1∑
j=1
πλ+1ij (β)
pi∗i (β)pi∗i (β)T
⊗ xixTi .
For the matrix ΩN,λ, we note that
ξi,λ (β) =
∑
y∗i∈Y∗
ui(y
∗
i ,β)f
λ+1
i (y
∗
i ,β)
=
d∑
j=1
ui(ej,d,β)f
λ+1
i (ej,d,β) + ui(0d,β)f
λ+1
i (0d,β)
=
d∑
j=1
πλ+1ij (β) {ej,d − pi∗i (β)} ⊗ xi − πλ+1i,d+1 (β)pi∗i (β)⊗ xi
=
pi∗(λ+1)i (β)−

d+1∑
j=1
πλ+1ij (β)
pi∗i (β)
⊗ xi.
So in the expression of ΩN,λ (β), we obtain
ξi,λ (β) ξi,λ (β)
T
=

pi∗(λ+1)i (β)−
d+1∑
j=1
πλ+1ij (β)
pi∗i (β)

pi∗(λ+1)i (β)−
d+1∑
j=1
πλ+1ij (β)
pi∗i (β)

T

⊗ xixTi
=
pi∗(λ+1)i (β)pi∗(λ+1)i (β)T −
d+1∑
j=1
πλ+1ij (β)
pi∗i (β)pi∗(λ+1)i (β)T
−
d+1∑
j=1
πλ+1ij (β)
pi∗(λ+1)i (β)pi∗i (β)T +
d+1∑
j=1
πλ+1ij (β)
2 pi∗i (β)pi∗i (β)T
⊗ xixTi ,
from which the desired expression for ΩN,λ (β) can be obtained in a straightforward manner.
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Proof of Theorem 2 of the main paper:
We have LT β̂λ − h = LT (β̂λ − β0) and
√
N(β̂λ − β0) L−→
N→∞
N (0d(k+1),Σλ (β0)) ,
with Σλ (β0) = limN→∞MN,λ(β̂λ) = J
−1
λ (β0)V λ (β0)J
−1
λ (β0). Therefore
√
N
(
LT β̂λ − h
) L−→
N→∞
N (0r,LTΣλ (β0)L)
and the asymptotic distribution of WN (β̂λ) is a chi-square distribution with r degrees of freedom
because
LTΣλ (β0)L
{
LTJ−1λ (β0)V λ (β0)J
−1
λ (β0)L
}−1
= Ir.
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Figure 2: Predicted category probabilities of the response variable, based on the MLE (left) and the
MDPDE with λ = 0.7 (right), for the three categories (j) of the Mammography experience data [Blue
circles: Full data; Orange triangles: Outlier deleted data].
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Figure 3: P-values of the proposed MDPDE based Wald-type tests for testing (a) H0 : βSYMPT11 = 0
in the Mammography data (left) and (b) H0 : β02 = 0 in the Liver enzyme data (right).
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Figure 4: MSEs (top panel) of the MDPDEs of β and the simulated levels (middle panel) and powers
(bottom panel) of the Wald-type tests under the pure data (left) and the contaminated data (right).
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Figure 5: Simulated MSEs of the MDPDEs at the optimally chosen λ, starting from different pilot
estimators under the pure data (left) and the contaminated data (right).
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A.4 Tables
27
Table 1: Minimum density power divergence estimators for the mammography data
λ β̂01,λ β̂SYMPT1,1,λ β̂SYMPT2,1,λ β̂SYMPT3,1,λ β̂HIST,1,λ β̂BSE,1,λ
0 -1.5787 1.1096 1.4157 0.3151 1.0685 1.0620
0.1 -1.6511 1.1699 1.3808 0.3249 1.0978 1.0706
0.2 -1.7270 1.2352 1.3607 0.3482 1.1193 1.1048
0.3 -1.7944 1.3256 1.3284 0.3585 1.1653 1.1745
0.4 -1.9113 1.3119 1.2913 0.3458 1.2427 1.2872
0.5 -2.0629 1.3763 1.2666 0.3371 1.3288 1.3704
0.6 -2.1549 1.4995 1.2402 0.3293 1.3743 1.3928
0.7 -2.2114 1.6137 1.2164 0.3188 1.4001 1.3812
0.8 -2.2511 1.7101 1.1955 0.3044 1.4186 1.3456
0.9 -2.2846 1.786 1.1754 0.2858 1.4294 1.301
1 -2.3139 1.8401 1.156 0.2646 1.4343 1.2574
λ β̂DETC1,1,λ β̂DETC2,1,,λ β̂PB,1,λ β̂02,λ β̂SYMPT1,2,λ β̂SYMPT2,2,λ
0 -0.6689 0.236 0.1485 1.4446 -1.3661 -0.9276
0.1 -0.5903 0.2141 0.1548 1.3131 -1.4693 -0.9747
0.2 -0.5265 0.1889 0.1616 1.1912 -1.6064 -1.0177
0.3 -0.4563 0.1729 0.1650 1.0880 -1.7353 -1.0571
0.4 -0.3068 0.1688 0.1724 1.0336 -1.7867 -1.0618
0.5 0.0080 0.1472 0.1832 0.9214 -1.7641 -1.0453
0.6 0.2614 0.1151 0.1919 0.8251 -1.7182 -1.0412
0.7 0.4167 0.0842 0.1986 0.7629 -1.6787 -1.0418
0.8 0.5100 0.0523 0.2041 0.7219 -1.6453 -1.0422
0.9 0.5619 0.0186 0.2101 0.6907 -1.6174 -1.0393
1 0.5878 -0.0137 0.2164 0.6675 -1.5848 -1.0309
λ β̂SYMPT3,2,λ β̂HIST,2,λ β̂BSE,2,λ β̂DETC1,2,λ β̂DETC2,2,λ β̂PB,2,λ
0 -0.2155 -0.3005 -0.2298 -1.5812 -0.6534 -0.0710
0.1 -0.1978 -0.2761 -0.2517 -1.7736 -0.7238 -0.0540
0.2 -0.1724 -0.2540 -0.2386 -1.8798 -0.7922 -0.0392
0.3 -0.1610 -0.1980 -0.1797 -1.9429 -0.8414 -0.0310
0.4 -0.1711 -0.1776 -0.0967 -1.9037 -0.8815 -0.0243
0.5 -0.1819 -0.1364 -0.0562 -1.6614 -0.9420 -0.0119
0.6 -0.1949 -0.0954 -0.0709 -1.4194 -1.0084 -0.0012
0.7 -0.2120 -0.0677 -0.0914 -1.2394 -1.0703 0.0065
0.8 -0.2337 -0.0484 -0.1127 -1.0941 -1.1362 0.0125
0.9 -0.2594 -0.0387 -0.1358 -0.9758 -1.2097 0.0186
1 -0.2876 -0.0362 -0.1559 -0.8796 -1.2855 0.0245
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Table 2: Minimum density power divergence estimators for the mammography data in absence of
outliers (distinct covariate indices 1, 3, 17, 35, 75, 81, and 102)
λ β̂01,λ β̂SYMPT1,1,λ β̂SYMPT2,1,λ β̂SYMPT3,1,λ β̂HIST,1,λ β̂BSE,1,λ
0 -1.8925 1.4266 1.3669 0.3256 1.1116 1.6248
0.1 -1.9181 1.4846 1.3406 0.3303 1.1473 1.6814
0.2 -1.9530 1.4341 1.3124 0.3184 1.2141 1.7322
0.3 -2.0763 1.3997 1.3008 0.3252 1.299 1.8002
0.4 -2.1994 1.4703 1.2857 0.334 1.3638 1.8316
0.5 -2.2740 1.5918 1.2690 0.3386 1.4018 1.8104
0.6 -2.3082 1.7108 1.2544 0.3381 1.4271 1.7601
0.7 -2.3281 1.7978 1.2461 0.3338 1.4402 1.6934
0.8 -2.2511 1.7101 1.1955 0.3044 1.4186 1.3456
0.9 -2.3616 1.8963 1.2391 0.3148 1.5180 1.5919
1 -2.3914 1.9706 1.2271 0.2943 1.5283 1.4638
λ β̂DETC1,1,λ β̂DETC2,1,,λ β̂PB,1,λ β̂02,λ β̂SYMPT1,2,λ β̂SYMPT2,2,λ
0 -0.3568 0.2915 0.1793 1.5959 -5.4674 -1.3728
0.1 -0.3155 0.2298 0.1806 1.5181 -4.5081 -1.2968
0.2 -0.2328 0.1896 0.1801 1.4976 -3.7857 -1.2253
0.3 -0.0204 0.1807 0.1862 1.4111 -3.1953 -1.1531
0.4 0.2309 0.1591 0.195 1.2880 -2.7678 -1.0862
0.5 0.4338 0.1286 0.2015 1.1915 -2.4453 -1.0338
0.6 0.5676 0.0986 0.2045 1.1360 -2.2082 -0.995
0.7 0.6432 0.0721 0.207 1.1174 -2.0422 -0.9631
0.8 0.6927 0.0440 0.2094 1.1162 -1.9315 -0.9355
0.9 0.7257 0.0441 0.2038 1.1455 -1.8532 -0.8839
1 0.7227 0.0063 0.2089 1.1462 -1.7657 -0.8674
λ β̂SYMPT3,2,λ β̂HIST,2,λ β̂BSE,2,λ β̂DETC1,2,λ β̂DETC2,2,λ β̂PB,2,λ
0 -0.3246 -0.4810 0.1545 -4.4961 -0.5605 -0.0756
0.1 -0.3105 -0.4198 0.2659 -3.6716 -0.6706 -0.0711
0.2 -0.3158 -0.3607 0.3383 -3.0346 -0.7600 -0.0736
0.3 -0.3074 -0.3102 0.4025 -2.4822 -0.8003 -0.0681
0.4 -0.3004 -0.2556 0.4036 -2.0631 -0.8515 -0.0573
0.5 -0.2997 -0.2048 0.3459 -1.7300 -0.9100 -0.049
0.6 -0.3054 -0.1604 0.2685 -1.4688 -0.9677 -0.0454
0.7 -0.3175 -0.1420 0.2092 -1.2732 -1.0205 -0.0437
0.8 -0.3369 -0.1310 0.1663 -1.1216 -1.0774 -0.0434
0.9 -0.3511 -0.0924 0.1685 -1.0401 -1.093 -0.0527
1 -0.3806 -0.1013 0.1065 -0.8946 -1.1813 -0.0492
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Table 3: Estimated mean deviations of the predicted probabilities with respect to the relative frequen-
cies for the mammography data in presence and the absence of outliers
With Outliers Without Outliers
λ m̂d1(β̂
pres
λ ) m̂d2(β̂
pres
λ ) m̂d3(β̂
pres
λ ) m̂d(β̂
pres
λ ) m̂d1(β̂
abs
λ ) m̂d2(β̂
abs
λ ) m̂d3(β̂
abs
λ ) m̂d(β̂
abs
λ )
0 0.2497 0.1627 0.2244 0.2123 0.2333 0.1424 0.2130 0.1962
0.1 0.2481 0.1611 0.2241 0.2111 0.2331 0.1443 0.2126 0.1967
0.2 0.2465 0.1600 0.2234 0.2100 0.2333 0.1459 0.2128 0.1973
0.3 0.2446 0.1592 0.2221 0.2086 0.2325 0.1479 0.212 0.1975
0.4 0.2424 0.1590 0.2202 0.2072 0.2311 0.1497 0.2105 0.1971
0.5 0.2393 0.1596 0.2174 0.2054 0.2299 0.1511 0.2097 0.1969
0.6 0.2368 0.1600 0.2156 0.2041 0.2293 0.1521 0.2096 0.1970
0.7 0.2354 0.1604 0.2147 0.2035 0.2293 0.1530 0.2097 0.1973
0.8 0.2346 0.1609 0.2144 0.2033 0.2293 0.1539 0.2102 0.1978
0.9 0.2342 0.1614 0.2145 0.2034 0.2296 0.1546 0.211 0.1984
1 0.2341 0.1621 0.2147 0.2036 0.2302 0.1559 0.2121 0.1994
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Table 4: Mean deviations between predicted probabilities in the presence and the absence of outliers,
mammography data
λ m̂d1(β̂
pres
λ , β̂
abs
λ ) m̂d2(β̂
pres
λ , β̂
abs
λ ) m̂d3(β̂
pres
λ , β̂
abs
λ ) m̂d(β̂
pres
λ , β̂
abs
λ )
0 0.0423 0.0295 0.0244 0.0321
0.1 0.0382 0.0254 0.0231 0.0289
0.2 0.0344 0.0231 0.0218 0.0264
0.3 0.0329 0.0205 0.0216 0.0250
0.4 0.0313 0.0177 0.0209 0.0233
0.5 0.0265 0.0165 0.0164 0.0198
0.6 0.0224 0.0159 0.0129 0.0171
0.7 0.0194 0.0157 0.0108 0.0153
0.8 0.0177 0.0159 0.0101 0.0146
0.9 0.0167 0.0170 0.011 0.0149
1 0.0151 0.0168 0.0100 0.0139
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Table 5: Minimum density power divergence estimators for the mammography data in the presence
and absence of outliers (observations 3, 101, 108, 116, 131 and 136) for the liver enzyme data
With Outliers Without Outliers
λ β̂01,λ β̂11,λ β̂21,λ β̂31,λ β̂01,λ β̂11,λ β̂21,λ β̂31,λ
0 -11.3562 -5.6253 8.7928 -2.6974 -13.7400 -6.0662 9.8171 -2.9305
0.1 -11.9074 -8.2968 12.0207 -3.7737 -13.7704 -11.9607 17.4944 -6.8940
0.2 -13.9013 -8.8064 13.0695 -4.1168 -14.3529 -12.2444 17.8452 -6.8712
0.3 -12.2642 -9.7634 13.6570 -3.9701 -15.3101 -11.7853 16.7262 -5.0802
0.5 -19.7314 -8.4364 13.9747 -4.3414 -32.3112 -10.4116 19.7954 -7.8408
0.7 -20.2738 -8.2416 13.8016 -4.1064 -21.8045 -9.2977 16.1602 -6.3050
0.9 -15.9960 -9.8613 14.085 -3.1146 -25.5161 -9.3104 16.2868 -5.1840
λ β̂02,λ β̂12,λ β̂22,λ β̂32,λ β̂02,λ β̂12,λ β̂22,λ β̂32,λ
0 6.0838 -6.6832 6.2269 -2.3655 5.7237 -7.0629 6.6722 -2.3064
0.1 6.7921 -8.9577 8.7550 -3.1893 7.9148 -12.4001 13.1958 -5.6809
0.2 7.7503 -9.7336 9.4087 -3.4241 8.0888 -12.9810 13.2378 -4.8349
0.3 7.5506 -10.4368 10.1915 -3.4620 8.1183 -12.1101 11.7976 -3.5897
0.5 10.1578 -10.1466 9.1995 -3.3291 12.4949 -11.5529 10.2186 -3.6970
0.7 10.3416 -9.9920 8.9252 -3.145 9.4703 -9.9344 9.3999 -3.6731
0.9 8.8516 -10.7851 9.8726 -2.7130 11.0658 -10.3511 8.8947 -2.6976
λ β̂03,λ β̂13,λ β̂23,λ β̂33,λ β̂03,λ β̂13,λ β̂23,λ β̂33,λ
0 -5.8146 -1.4866 2.0449 1.1873 -6.7381 -2.1027 2.6535 1.5256
0.1 -5.9428 -2.1120 2.7574 1.1689 -6.8763 -2.8613 3.6163 1.3250
0.2 -6.0419 -2.2494 2.9226 1.1696 -6.9709 -2.8159 3.5948 1.3484
0.3 -6.0837 -2.7485 3.3916 1.2724 -6.4149 -3.5845 4.1865 1.5139
0.5 -7.2092 -2.7256 3.5795 1.3007 -8.5194 -3.1961 4.2202 1.4999
0.7 -7.9578 -2.9992 3.9547 1.3981 -6.8510 -2.9633 3.6638 1.4231
0.9 -6.7793 -3.4111 4.1136 1.4402 -8.4754 -3.6218 4.5947 1.5834
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Table 6: Estimated mean deviations of the predicted probabilities with respect to the relative frequen-
cies in the presence and the absence of outliers, for the liver enzyme data
With Outliers
λ m̂d1(β̂
pres
λ ) m̂d2(β̂
pres
λ ) m̂d3(β̂
pres
λ ) m̂d4(β̂
pres
λ ) m̂d(β̂
pres
λ )
0 0.0810 0.1041 0.1922 0.1867 0.1410
0.1 0.0732 0.0899 0.1831 0.1694 0.1289
0.2 0.0677 0.0834 0.1791 0.1656 0.1240
0.3 0.0702 0.0831 0.1753 0.1586 0.1218
0.5 0.0596 0.0750 0.1653 0.1548 0.1137
0.7 0.0597 0.0748 0.1603 0.1497 0.1111
0.9 0.0635 0.0761 0.1657 0.1484 0.1135
Without Outliers
λ m̂d1(β̂
abs
λ ) m̂d2(β̂
abs
λ ) m̂d3(β̂
abs
λ ) m̂d4(β̂
abs
λ ) m̂d(β̂
abs
λ )
0 0.0739 0.0970 0.1759 0.1704 0.1293
0.1 0.0656 0.0796 0.1643 0.1512 0.1152
0.2 0.0651 0.0772 0.1663 0.151 0.1149
0.3 0.0622 0.0748 0.1657 0.1479 0.1126
0.5 0.0501 0.0667 0.153 0.1447 0.1036
0.7 0.0557 0.0758 0.1609 0.154 0.1116
0.9 0.0540 0.0707 0.1540 0.1431 0.1054
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Table 7: Mean deviations between predicted probabilities in the presence and the absence of outliers,
for the liver enzyme data
λ m̂d1(β̂
pres
λ , β̂
abs
λ ) m̂d2(β̂
pres
λ , β̂
abs
λ ) m̂d3(β̂
pres
λ , β̂
abs
λ ) m̂d4(β̂
pres
λ , β̂
abs
λ ) m̂d(β̂
pres
λ , β̂
abs
λ )
0 0.0115 0.0103 0.0256 0.0242 0.0179
0.1 0.0130 0.0223 0.0316 0.0306 0.0244
0.2 0.0146 0.0187 0.0222 0.0226 0.0195
0.3 0.0126 0.0139 0.017 0.0177 0.0153
0.5 0.0138 0.0121 0.0193 0.0152 0.0151
0.7 0.0120 0.0134 0.0129 0.0113 0.0124
0.9 0.0167 0.0170 0.0228 0.0128 0.0173
34
B Supplementary Materials: R codes used for the computations in
Section 6.2
The following R codes are is provided to help reader to implementation the proposed MDPDE and the
corresponding Wald-type tests for any practical application. These codes were used for our simulation
studies presented in Section 6.2 of the main paper.
# ##############################################
#DEFINITION OF FUNCTIONS
PLRM <-function (x,beta ){
# ##############################################
#INPUTS
#x: vector of explanatory variables , dim --1xk
#beta : vector of unknown parameters : dxk
#OUTPUT
#pisol: vector of probabilities of all categories , dim --1x(d+1)
# ##############################################
k=length(x)
d=length(beta )/k
betat=matrix(beta ,k,d)
pisol=exp(x%*% betat)/(1+sum(exp(x%*% betat)))
pisol=c(pisol ,1-sum(pisol))
return(pisol)
}
DISTANCE <-function (beta ,lambda ,X,Y,n){
# ##############################################
#INPUTS
#beta : vector of unknown parameters : dxk
#lambda: tuning parameter of power divergences
#X: matrix of explanatory variables , dim --Nxk
#Y: matrix of responses , dim --kx(d+1)
#n:vector of sizes n(x), dim --1xN
#OUTPUT
#divsol: power divergence distance
# ##############################################
N=dim(X)[1]
d=length(beta )/( dim(X)[2])
#initialize
divsol=0
#DPD (lambda!=0)
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if (lambda !=0){
for (i in 1:N){
pis=PLRM (X[i,], beta )
for (l in 1:(d+1)){
divsol=divsol+ (n[i]* pis[l])^(1+lambda) -(1+1/lambda)*Y[i,l]*(n[i]* pis[l])^( lambda)
}
}
}
#MLE (lambda==0)
else {
for (i in 1:N){
pis=PLRM (X[i,], beta )
for (l in 1:(d+1)){
if (Y[i,l]==0){divsol=divsol+0}
else {divsol=divsol+ Y[i,l]*log(Y[i,l]/(n[i]* pis[l]))}
}
}
}
return(divsol)
}
TEST <-function (beta ,lambda ,Y,X, PIS ,L){
# ##############################################
#INPUTS
#beta : vector of unknown parameters : dxk
#lambda: tuning parameter of power divergences
#Y: matrix of responses , dim --kx(d+1)
#X: matrix of explanatory variables , dim --Nxk
#PIS: matrix of probabilities under the model
#L: matrix of the contrast
#OUTPUT
#M: matrix of the Wald -type test
# ##############################################
d=dim(Y)[2]-1
N=dim(X)[1]
tol= 1e-12 #to discard non -invertible matrices
#initialize
PHIM =matrix(0,length(beta ),length(beta ))
OMEGAM=matrix(0,length(beta ),length(beta ))
for (i in 1:N){
#definition of auxiliar variables
clambda=sum(PIS[i,]^( 1+lambda))
cdoslambda =sum(PIS[i,]^( 1+2*lambda))
etai =kronecker (PIS[i,1:d]^(1+lambda)-clambda *PIS[i,1:d],X[i,])
#computation of matrices Phi and Omega
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PHIM =PHIM +kronecker (diag (PIS[i,1:d]^(1+lambda))-PIS[i,1:d]%*%t(PIS[i,1:d]^(1+lambda))
-PIS[i,1:d]^(1+lambda)%*%t(PIS[i,1:d])+ clambda *PIS[i,1:d]%*%t(PIS[i,1:d]),X[i,]
%*%t(X[i,]))
OMEGAM=OMEGAM+kronecker (diag (PIS[i,1:d]^(1+2*lambda))-PIS[i,1:d]%*%t(PIS[i,1:d]^(1+2*
lambda))-PIS[i,1:d]^(1+2*lambda)%*%t(PIS[i,1:d])+ cdoslambda *PIS[i,1:d]%*%t(PIS[i
,1:d]),X[i,] %*%t(X[i,]))-etai %*%t(etai )
}
if (det(PHIM )<tol){M=NULL }
else {
aux=t(L)%*% solve(PHIM )%*% OMEGAM %*% solve(PHIM )%*%L
if(det(aux)<tol){M=NULL }
else {M=solve(aux)}
}
return(M)
}
# ##############################################
#SIMULATION
set.seed (2509) #set the seed
Samples=1000 # number of samples in the simulation
beta 0=c(0,-0.9,0.1,0.6,-1.2,0.8) #true value of the variable vector
N=c(100,125,150,175,200,225,250,275,300,325) #samples sizes considered
lambda=c(0,0.1,0.2,0.3,0.5,0.7,0.9) #lambdas considered for the MDPDEs
out=0.95 #percentage of pure data
# We will contrast the null hypothesis H0:beta 02=0.6 with 1 degree of freedom
L=matrix(0,6,1)
L[4,1]=1
ll=matrix(0.6,1,1)
valid_samples=matrix(Samples ,length(lambda),length(N)) #initialize the number of
valid samples
level_model_without _outliers =matrix(0,length(lambda),length(N)) #matrix of levels for
the pure case
level_model_with _outliers =matrix(0,length(lambda),length(N)) #matrix of levels for
the contaminated case
initial=c(0,0,0,0,0,0) #initialize the value of the parameter vector
#LOOP FOR THE SIMULATION
for (l in 1:length(N)){
#definition of parameters which depend on the size of N
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n=vector(,N[l])+1
PIS=matrix(0,N[l],3)
PIS1=PIS
PIS2=PIS
Y=matrix(0,N[l],3)
for (s in 1:Samples ){
#definition of parameters which vary for each sample
#generation fo the matrix X
x0=vector(,N[l])+1
x1=rnorm(N[l],0,1)
x2=rnorm(N[l],0,1)
X=cbind(x0,x1,x2)
for (i in 1:N[l]){
PIS[i,]= PLRM (X[i,],beta 0)
Y[i,]= rmultinom ( 1,n[i],PIS[i,])
}
#change in the response variable for outliers
Y2=Y
for (i in floor(out*N[l]):N[l]){
aux=c(Y[i,3],Y[i,1],Y[i,2])
Y2[i,]= aux
}
#calculation for each lambda
for (r in 1:length(lambda)){
#estimation of the vector of parameters beta
aux_model_without _outliers =tryCatch (nlm(DISTANCE ,initial ,lambda[r],X,Y,n ),error=
function(sol){sol$code =3;return(sol)})
aux_model_with_ outliers =tryCatch (nlm(DISTANCE ,initial ,lambda[r],X,Y2,n ),error=
function(sol){sol$code =3;return(sol)})
beta _model_without _outliers =aux_model_without _outliers $ estimate
beta _model_with _outliers =aux_model_with _outliers $estimate
#if the minimization does not converge : we delete this sample
if(length(beta_model_without_ outliers )==0){valid_samples [r,l]= valid_samples [r,l]-1}
else if(length(beta _model_with _outliers )==0){valid_samples [r,l]= valid_ samples[r,l]-1}
else {
#estimated probabilities , depend on lambda
for (i in 1:N[l]){
PIS1[i,]= PLRM (X[i,],beta _model_without_outliers )
PIS2[i,]= PLRM (X[i,],beta _model_with _outliers )
}
#finally , the estimation of the test matrices
test _without_outliers =TEST (beta _model_without _outliers ,lambda[r],Y,X, PIS1,L)
test _with _outliers =TEST (beta_model_with _outliers ,lambda[r],Y2,X, PIS2,L)
#what happens if it is not invertible ?: we delete this sample
if (length(test _without_outliers )==0){valid_samples[r,l]= valid_samples [r,l]-1}
else if (length( test _with _outliers )==0){valid_samples[r,l]= valid_samples [r,l]-1}
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#if everything ’s ok , let ’s compute the levels
else {
result_model_without _outliers =(t(L) %*% beta _model_without _outliers -ll)%*% test _
without _outliers %*%t((t(L) %*% beta _model_without_outliers -ll))
result_model_with _outliers =(t(L) %*% beta_model_with _outliers -ll)%*% test _with _
outliers %*%t((t(L) %*% beta _model_with _outliers -ll))
#the asymptotic distribution under the null hypothesis is a chi -square distribution
with 1 degree of freedom
level_model_without _outliers [r,l]= level_model_without_outliers [r,l]+( result_model_
without _outliers >qchisq(0.95, df=1))
level_model_with _outliers [r,l]= level_model_with _outliers [r,l]+( result_model_with _
outliers >qchisq(0.95, df=1))
}
}
}
}
}
#taking into account the valid samples , we obtain the final values
levels_without_ outliers =level_model_without _outliers /valid_samples
levels_with _outliers =level_model_with _outliers /valid_samples
# ##############################################
#RESULTS
#names of rows and cols
row.names(levels_without_outliers )=c(lambda)
row.names(levels_with _outliers )=c(lambda)
colnames (levels_without_outliers )=c(N)
colnames (levels_with _outliers )=c(N)
#print on screen
(levels_without _outliers )
(levels_with _outliers )
#plotting the results
x_axis =N
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#plotting the pure case
level=levels_without _outliers
par(mar=c(5.1, 4.1,5.1, 6.1), xpd=FALSE)
#print the levels of the MLE
plot (x_axis ,level[1 ,],xlim =c(min(x_axis ),max(x_axis )),ylim =c(0.03,0.07),xlab =
expression (N),ylab =c("Level"),col=1,"o",lty=1, pch=1)
abline(a=NULL ,b=NULL ,v=x_axis ,col="lightgray ", lty = 3)
abline(a=NULL ,b=NULL ,h=c(0:100)/(100),col="lightgray ", lty = 3)
abline(a=NULL ,b=NULL ,h=c(0.05), lty = 3) #for the significance level alpha=0.05
#print the levels of the alternative MDPDEs
for (j in 2:length(lambda)){
lines(x_axis ,level[j,],col=j,"o",lty=j, pch=j)
}
#print the legend
par(mar=c(5.1, 3.1,5.1, 6.1), xpd=TRUE )
legend("topright ", title= expression (lambda),horiz=F, inset=c(-0.28,0), as.character (
lambda), col = c(1:length(lambda)), lty = c(1:length(lambda)), ,pch = c(1:length(
lambda)))
#plotting the contaminated case
level=levels_with _outliers
par(mar=c(5.1, 4.1,5.1, 6.1), xpd=FALSE)
#print the levels of the MLE
plot (x_axis ,level[1 ,],xlim =c(min(x_axis ),max(x_axis )),ylim =c(0.03,max(level)),xlab=
expression (N),ylab =c("Level"),col=1,"o",lty=1, pch=1)
abline(a=NULL ,b=NULL ,v=x_axis ,col="lightgray ", lty = 3)
abline(a=NULL ,b=NULL ,h=c(0:10)/(10),col=" lightgray ", lty = 3)
abline(a=NULL ,b=NULL ,h=c(0.05), lty = 3) #for the significance level alpha=0.05
#print the levels of the alternative MDPDEs
for (j in 2:length(lambda)){
lines(x_axis ,level[j,],col=j,"o",lty=j, pch=j)
}
#print the legend
par(mar=c(5.1, 3.1,5.1, 6.1), xpd=TRUE )
legend("topright ", title= expression (lambda),horiz=F, inset=c(-0.28,0), as.character (
lambda), col = c(1:length(lambda)), lty = c(1:length(lambda)), ,pch = c(1:length(
lambda)))
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